Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
CTKB is expected to report earnings to fall 80.78% to -1 cents per share on August 12
Q2'25
Est.
$-0.02
Q1'25
Missed
by $0.07
Q4'24
Beat
by $0.01
Q3'24
Est.
$0.01
Q2'24
Missed
by $0.08
The last earnings report on May 08 showed earnings per share of -9 cents, missing the estimate of -1 cents. With 505.99K shares outstanding, the current market capitalization sits at 876.52M.